Skip to search formSkip to main contentSkip to account menu

Thrombocytopenic purpura

Known as: Thrombopenic Purpuras, Thrombopenic purpura, Purpura, Thrombocytopenic 
Any form of purpura in which the PLATELET COUNT is decreased. Many forms are thought to be caused by immunological mechanisms.
National Institutes of Health

Related topics

Related topics

33 relations

Narrower (5)

Acquired amegakaryocytic thrombocytopeniaCongenital thrombocytopeniaImmune thrombocytopenic purpuraPosttransfusion purpura
Danaparoid sodiumDicumarolEvans syndromeHematopoietic and Lymphoid Cell

Broader (2)

PurpuraThrombocytopenia

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome
Thrombotic thrombocytopenic purpura (TTP) and atypical haemolytic uraemic syndrome (aHUS) are acute, rare life‐threatening… 
Highly Cited
2013
Highly Cited
2013
Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse
Rituximab has been documented in the treatment of acute (≤ 3 days from admission), relapsed/refractory thrombotic… 
Highly Cited
2011
Highly Cited
2011
Complement activation in thrombotic thrombocytopenic purpura
Summary.  Background:  Ultra‐large von Willebrand factor and deficiency of its cleaving protease are important factors in the… 
Review
2009
Review
2009
Renal vulnerability to drug toxicity.
Drug-induced kidney disease occurs primarily in patients with underlying risk factors. A number of factors enhance the… 
Review
2005
Review
2005
Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation.
Highly Cited
2003
Highly Cited
2003
Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura.
Acquired thrombotic thrombocytopenic purpura (TTP) has been linked to severe deficiency of ADAMTS-13 activity caused by… 
Review
2003
Review
2003
Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases.
CONTEXT Thrombotic thrombocytopenic purpura (TTP) and the hemolytic uremic syndrome (HUS) share many clinical features and have… 
Highly Cited
2003
Highly Cited
2003
Hematopoietic stem cell and progenitor defects in Sca-1/Ly-6A-null mice.
Despite its wide use as a marker for hematopoietic stem cells (HSCs), the function of stem cell antigen-1 (Sca-1) (also known as… 
Review
1989
Review
1989
Renal vascular and thrombotic effects of cyclosporine.
Highly Cited
1977
Highly Cited
1977
Treatment of thrombotic thrombocytopenic purpura with plasma.
Thrombotic thrombocytopenic purpura, the acute form of which is usually fatal, is characterized clinically by thrombocytopenia… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)